What to do when medication causes secondary psychological injury
Evaluating causation and managing funding when prescribed medications trigger psychiatric symptoms
Published: 3 April 2026 | Updated: 3 April 2026
The scenario you're facing
A claimant was injured in a workplace accident. They were prescribed pain medication, which worked for the physical injury. Months later, they develop depressive symptoms or anxiety. They claim the medication caused the psychological injury, and they want your scheme to fund treatment. Now you're wondering: did the medication actually cause this, or is the depression secondary to the injury itself? And if the medication is responsible, where does your liability begin and end?
This is a causation problem dressed as a medication problem. You need clarity on both.
Understanding medication-induced psychiatric adverse effects
Some medications genuinely can cause psychiatric symptoms. This isn't uncommon, and it's not always obvious. Common culprits include:
- Corticosteroids: Can cause mood changes, anxiety, psychosis at higher doses
- Opioids: Associated with depression, hyperalgesia (paradoxical pain increase), and psychological dependence
- Benzodiazepines: Can cause paradoxical anxiety, emotional blunting, depression with long-term use
- Anticonvulsants: Some (levetiracetam, topiramate) linked to mood disturbances and behavioral changes
- Anticholinergics: Can cause anxiety, confusion, and cognitive dysfunction
- Muscle relaxants: Tizanidine and baclofen can cause depression and suicidal ideation
- Certain pain medications: Tramadol has serotonin activity and can cause agitation or emotional lability
But here's the complexity: psychiatric symptoms are also common secondary responses to serious injury, pain, functional limitation, and loss of work. Distinguishing medication-induced effects from psychological responses to the injury itself requires careful analysis.
The causation challenge: The claimant has both (a) an injury that would reasonably cause psychological distress and (b) medications that can sometimes cause psychiatric symptoms. Determining which is responsible requires evidence and clinical reasoning, not assumptions.
Your assessment framework
When a claimant claims medication-induced psychological injury, evaluate these factors systematically:
1. Temporal relationship: did psychiatric symptoms appear after medication started or escalated?
If psychiatric symptoms began weeks or months before the medication started, the medication didn't cause them. If they appeared within days or weeks of starting a medication known to cause psychiatric effects, the temporal relationship is stronger. If symptoms began long after the medication was started (6+ months), it's less likely to be medication-induced. Timeline matters.
2. Is the medication known to cause psychiatric effects?
Some medications have well-documented psychiatric adverse effects. Others don't. If the claimant is on an SSRI (which can sometimes cause akathisia or agitation early in treatment) that's different from being on paracetamol. Check the product information and pharmacology. Does this medication have a known psychiatric risk profile?
3. Did symptoms resolve when the medication was ceased or dose-reduced?
This is the strongest evidence. If psychiatric symptoms improved significantly or resolved within days or weeks of stopping or reducing a suspected medication, this supports causation. Request documentation of the medication change and the timing of symptom improvement.
4. Are there documented psychiatric risk factors unrelated to the injury or medication?
Some claimants have pre-existing psychiatric conditions, family history of mental illness, or social stressors unrelated to the injury. These increase vulnerability to depression and anxiety. If the claimant has significant pre-existing or concurrent psychiatric risk factors, attributing all psychiatric symptoms to the medication becomes harder to justify.
5. Is the dose within or above the typical range?
Psychiatric adverse effects from medications are often dose-dependent. At therapeutic doses, the risk is typically lower than at high doses. If the claimant is on a high dose of a medication with psychiatric risks, causation is more plausible than if they're on a standard dose.
6. Are there alternative explanations for the psychiatric symptoms?
The injury itself, ongoing pain, functional limitation, unemployment, social isolation, or loss of identity (from the injury) can all cause depression and anxiety. These are normal psychological responses to serious injury. The medication might be contributing, but it may not be the primary cause.
Common scenarios and decision pathways
Scenario A: Strong evidence of medication causation
Example: Claimant started on levetiracetam for post-TBI seizure prophylaxis. Within 3 weeks, they developed significant suicidal ideation (not present before). Psychiatric assessment notes the timing. Symptoms resolved within 2 weeks of switching to a different anticonvulsant.
Your call: The medication likely caused the psychiatric injury. This is a complication of the initial treatment and falls within your scheme's responsibility. Fund appropriate psychiatric treatment and ensure the medication is not re-prescribed. An independent medication review would document this causation for your records.
Scenario B: Plausible medication contribution but concurrent psychological injury from the original injury
Example: Claimant on opioids long-term for persistent pain. Develops depression after 9 months. Timeline is consistent with medication-induced depression, but the claimant also has legitimate pain disability, loss of work, and significant functional limitation. Pre-existing mental health history exists but was stable before the injury.
Your call: The medication may be contributing, but it's likely not the sole cause. The depression is multifactorial. Consider whether deprescribing opioids or switching to alternatives (with specialist pain input) would help. Fund psychological treatment. The psychiatric symptoms are compensable (secondary to the injury), but the medication is likely a modifier, not the primary cause. A medication review could help clarify the contribution and identify optimizations.
Scenario C: Psychiatric symptoms attributable to the injury; medication may be incidental
Example: Claimant with severe traumatic brain injury (understandably) develops depression and PTSD. They're on gabapentin and various other medications. Timeline shows psychiatric symptoms emerged over weeks as they realized the severity of their injury, not coinciding with any medication change. Pre-existing mental health factors don't explain this entirely.
Your call: The psychiatric injury is secondary to the injury itself, not to the medication. The depression and trauma are understandable psychological responses. Medications are supporting symptom management, not causing the injury. Fund psychiatric and psychological treatment as part of the injury claim. No medication-specific causation argument stands here.
Getting expert input: when to refer for a pharmacy review
Medication-induced psychiatric adverse effects require clinical judgment. Refer for a pharmacy review when:
- The temporal relationship between medication start/change and psychiatric symptoms is unclear
- The claimant is on multiple medications that could potentially cause psychiatric effects
- You want documentation of whether switching or ceasing a medication is likely to improve psychiatric symptoms
- The claimant, prescriber, or mental health provider disagree about medication causation
- You're considering deprescribing to test whether psychiatric symptoms improve
Causation and your scheme's responsibility
Here's where the legal and medical lines blur. Your scheme is responsible for funding treatment of injuries and their direct medical consequences. If a medication you funded caused psychiatric injury, that's arguably your responsibility. But if psychiatric symptoms resulted from the original injury and the medication just happened to coincide, that's different.
In practice:
- If medication clearly caused psychiatric injury: Your scheme should fund treatment and change the medication. This is a complication of your funded treatment
- If psychiatric injury is secondary to the original injury (even if medication is contributing): Your scheme's responsibility may be to fund optimal psychiatric treatment, which might include medication optimization
- If psychiatric injury predates the injury or medication: This is outside your scheme's responsibility, unless it's been significantly exacerbated
The worst outcome is ongoing funding of a medication that's harming your claimant's psychology. If there's genuine concern about medication causation, your action should be to optimize or change the medication, not to indefinitely fund treatment of the alleged injury while continuing the suspected cause.
| Evidence Pattern | Likely Causation | Scheme Responsibility |
|---|---|---|
| Psychiatric symptoms start 2 weeks after medication began; resolve within 2 weeks of stopping it; no pre-existing psychiatric history | Medication caused psychiatric injury | Fund psychiatric treatment; don't fund continued medication |
| Psychiatric symptoms start months after medication began; timeline doesn't align with dose changes; claimant has significant pain disability | Multifactorial; medication may contribute but injury is primary cause | Fund psychiatric treatment and medication optimization |
| Psychiatric symptoms present before injury; slightly worsened by medication or injury; no clear temporal alignment | Pre-existing condition; medication not primary cause | Fund treatment for exacerbation of pre-existing condition; medication adjustment optional |
| Psychiatric symptoms clearly secondary to severe injury; medication not suspected | Injury caused psychiatric injury | Fund psychiatric treatment as part of injury claim |
Documentation and evidence requests
Before deciding the claim, request:
- Psychiatric assessment notes with timeline of symptom onset relative to medication initiation or dose changes
- Prescriber notes on why the medication was chosen and whether psychiatric adverse effects were discussed
- Documentation of any medication changes and the timing and nature of symptom response
- Medical history showing pre-injury and post-injury psychiatric status
- Any suicide risk assessments or behavioral observations relevant to the psychiatric symptoms
- Records of the claimant's functional status before and after psychiatric symptom onset
Practical strategies for moving forward
If medication causation is plausible: Work with the prescriber to optimize medication management. This might mean ceasing the suspected medication, reducing the dose, switching to an alternative with lower psychiatric risk, or adding medication to counteract the adverse effect. Test whether psychiatric symptoms improve with medication adjustment. This is both clinical and evidence.
Concurrently, fund psychological treatment: Even if the medication is contributing, the claimant will benefit from psychological support. This addresses psychological coping, resilience, and adaptive strategies unrelated to medication.
Avoid indefinite funding of a medication-injury combination: Don't keep funding a medication indefinitely while simultaneously funding treatment for its alleged adverse effects. That's expensive and doesn't serve the claimant well. Either the medication is causing injury (change it) or it isn't (no causation claim holds).
Key takeaways
- Medication-induced psychiatric injury is real but must be distinguished from psychiatric injury secondary to the original injury
- Use temporal relationship, known adverse effects, dose, and response to cessation as your causation indicators
- Pre-existing psychiatric factors and concurrent stressors should be considered
- Refer for a pharmacy review when causation is unclear or medication optimization is needed
- Your scheme's responsibility depends on whether the medication genuinely caused the injury or whether the injury is secondary to the original trauma
- Take action: if medication is suspected, optimize or change it. Don't indefinitely fund both the medication and treatment of its alleged harms
Unclear whether a medication caused psychiatric symptoms?
IMM's pharmacists untangle complex medication-psychiatric symptom relationships. We evaluate causation evidence, assess medication contribution, and recommend optimization strategies. We liaise with prescribers to ensure safe, evidence-based medication adjustments that prioritize claimant psychology.
Request a Medication Review
